@ARTICLE{
author={Zimran Ari,Duran Gloria,Giraldo Pilar,Rosenbaum Hanna,Giona Fiorina,Petakov Milan S,Terreros Munoz Eduardo,Eduardo Solorio-Meza Sergio,Cooper Peter A,Varughese Sheeba,Alon Sari,Chertkoff Raul},
year={2019},
title={Long-term efficacy and safety results of taliglucerase alfa through 5 years in adult treatment-naive patients with Gaucher disease},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={78},
number={},
pages={14-21},
document_type={Article},
} 

@ARTICLE{
author={Zimran Ari,Gonzalez-Rodriguez Derlis Emilio,Abrahamov Aya,Cooper Peter A,Varughese Sheeba,Giraldo Pilar,Petakov Milan S,Tan Ee Shien,Chertkoff Raul},
year={2018},
title={Long-term safety and efficacy of taliglucerase alfa in pediatric Gaucher disease patients who were treatment-naive or previously treated with imiglucerase},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={68},
number={},
pages={163-172},
document_type={Article},
} 

@ARTICLE{
author={Pastores Gregory M,Shankar Suma P,Petakov Milan S,Giraldo Pilar,Rosenbaum Hanna,Amato Dominick J,Szer Jeffrey,Chertkoff Raul,Brill-Almon Einat,Zimran Ari},
year={2016},
title={Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={91},
number={7},
pages={661-665},
document_type={Article},
} 

@ARTICLE{
author={Zimran Ari,Duran Gloria,Mehta Atul,Giraldo Pilar,Rosenbaum Hanna,Giona Fiorina,Amato Dominick J,Petakov Milan S,Munoz Eduardo Terreros,Solorio-Meza Sergio Eduardo,Cooper Peter A,Varughese Sheeba,Chertkoff Raul,Brill-Almon Einat},
year={2016},
title={Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-naive patients with Gaucher disease},
journal={AMERICAN JOURNAL OF HEMATOLOGY},
volume={91},
number={7},
pages={656-660},
document_type={Article},
} 

@ARTICLE{
author={Pastores Gregory M,Petakov Milan S,Giraldo Pilar,Rosenbaum Hanna,Szer Jeffrey,Deegan Patrick B,Amato Dominick J,Mengel Eugen,Tan Ee Shien,Chertkoff Raul,Brill-Almon Einat,Zimran Ari},
year={2014},
title={A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={53},
number={4},
pages={253-260},
document_type={Article},
} 

@ARTICLE{
author={Zimran Ari,...,Petakov Milan S,...,(broj koautora 21)},
year={2011},
title={Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease},
journal={BLOOD},
volume={118},
number={22},
pages={5767-5773},
document_type={Article},
} 

@ARTICLE{
author={Elstein Deborah,Foldes Joseph A,Zahrieh David,Cohn Gabriel M,Djordjevic Maja S,Brutaru Costin,Zimran Ari},
year={2011},
title={Significant and continuous improvement in bone mineral density among type 1 Gaucher disease patients treated with velaglucerase alfa: 69-month experience, including dose reduction},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={47},
number={1},
pages={56-61},
document_type={Article},
}